Original Research
Accepted on 27 Jan 2026
Identification of plasma inflammatory biomarkers for Alzheimer's disease reveals IFN-γ as a regulator of ACSL1-mediated microglia phenotype
in Multiple Sclerosis and Neuroimmunology
- 398 views
Original Research
Accepted on 27 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Review
Published on 27 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 27 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Review
Published on 27 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Review
Published on 26 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Editorial
Published on 22 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Systematic Review
Published on 21 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Brief Research Report
Published on 15 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 14 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 14 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Correction
Published on 13 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 12 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Mini Review
Published on 12 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 12 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 12 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Review
Published on 09 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Review
Published on 09 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 08 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 07 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 06 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 05 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Clinical Trial
Published on 05 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 02 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 02 Jan 2026
in Multiple Sclerosis and Neuroimmunology